Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001826466-25-000030
Filing Date
2025-03-31
Accepted
2025-03-31 13:45:42
Documents
51
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form-10k.htm   iXBRL 10-K 393977
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 7179
3 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3421
4 GRAPHIC fruciauditopinionx1x1.jpg GRAPHIC 3053
5 GRAPHIC fruciauditopinionx2x1.jpg GRAPHIC 2043
  Complete submission text file 0001826466-25-000030.txt   2334500

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nika-20241231.xsd EX-101.SCH 20024
7 XBRL CALCULATION FILE nika-20241231_cal.xml EX-101.CAL 23744
8 XBRL DEFINITION FILE nika-20241231_def.xml EX-101.DEF 78973
9 XBRL LABEL FILE nika-20241231_lab.xml EX-101.LAB 167803
10 XBRL PRESENTATION FILE nika-20241231_pre.xml EX-101.PRE 149873
54 EXTRACTED XBRL INSTANCE DOCUMENT form-10k_htm.xml XML 180114
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

EIN.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56234 | Film No.: 25791437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)